Xtant Medical to Present at the Rodman Renshaw 17th Annual Global Investment Conference

Xtant Medical to Present at the

Rodman Renshaw 17th Annual Global Investment Conference

BELGRADE, Mont., August

27, 2015 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (OTCQX:BONE), formerly Bacterin International Holdings, Inc., a

leader in the development of class-leading regenerative medicine products and medical devices, today announced that its Chief

Executive Officer, Dan Goldberger, Chief Financial Officer, John Gandolfo and Executive Vice President and Chief Scientific

Officer Dr. David Kirschman will present at the Rodman Renshaw 17th Annual Global Investment Conference, to be held September

8 - 10, 2015 at the St. Regis Hotel in New York City, New York. Xtant Medical's presentation will take place Wednesday,

September 9, 2014 at 12:05 PM Eastern Time.

A live broadcast of the conference

presentation will be available. To access the broadcast, go to the "Investor Info" section of the Company's website at

www.bacterin.com. A replay of the conference presentation will also be available.

About Xtant Medical Holdings

Xtant Medical Holdings,

Inc. (OTCQX: BONE) develops, manufactures and markets class-leading regenerative medicine products and medical devices for domestic

and international markets. Xtant products serve the specialized needs of orthopedic and neurological surgeons, including orthobiologics

for the promotion of bone healing, implants and instrumentation for the treatment of spinal disease, tissue grafts for the treatment

of orthopedic disorders, and biologics to promote healing following cranial, foot and ankle surgeries. With core competencies in

both biologic and non-biologic surgical technologies, Xtant can leverage its resources to successfully compete in global neurological

and orthopedic surgery markets. For further information, please visit www.xtantmedical.com.

Important Cautions Regarding

Forward-looking Statements

This press release contains certain

disclosures that may be deemed forward-looking statements within the meaning of the Private Securities Litigation Reform Act

of 1995 that are subject to significant risks and uncertainties. Forward-looking statements include statements that are

predictive in nature, that depend upon or refer to future events or conditions, or that include words such as

"continue," "efforts," "expects," "anticipates," "intends,"

"plans," "believes," "estimates," "projects," "forecasts,"

"strategy," "will," "goal," "target," "prospects," "potential,"

"optimistic," "confident," "likely," "probable" or similar expressions or the

negative thereof. Statements of historical fact also may be deemed to be forward-looking statements. We caution that

these statements by their nature involve risks and uncertainties, and actual results may differ materially depending on a

variety of important factors, including, among others: the Company's ability to successfully integrate the acquisition of

X-spine; the ability of the Company's sales force

to achieve expected results, the

Company's ability to meet its existing and anticipated contractual obligations, including financial covenant and other obligations

contained in the Company's secured lending facility; the Company's ability to manage cash flow; the Company's ability to develop,

market, sell and distribute desirable applications, products and services and to protect its intellectual property; the ability

of the Company's customers to pay and the timeliness of such payments; the Company's ability to obtain financing as and when needed;

changes in consumer demands and preferences; the Company's ability to attract and retain management and employees with appropriate

skills and expertise; the impact of changes in market, legal and regulatory conditions and in the applicable business environment,

including actions of competitors; and other factors. Additional risk factors are listed in the Company's Annual Report on Form

10-K and Quarterly Reports on Form 10-Q under the heading "Risk Factors." The Company undertakes no obligation to release

publicly any revisions to any forward-looking statements to reflect events or circumstances after the date hereof or to reflect

the occurrence of unanticipated events, except as required by law.